
    
      This will be a prospective, randomized, double-blinded, controlled, multi-center,
      dose-verification clinical study in subjects who require surgical intervention to treat a
      qualifying periodontal defect.

      Subjects 25 years and older with advanced periodontal disease in at least one site requiring
      surgical treatment to correct a bone defect.
    
  